本文已被:浏览 322次 下载 190次
投稿时间:2025-04-28 网络发布日期:2025-08-20
投稿时间:2025-04-28 网络发布日期:2025-08-20
中文摘要: 脓毒症是一种由感染引起的全身反应综合征,其导致的器官功能障碍是致命的关键,肺脏是脓毒症最易累及的器官。近年来研究表明,中药有效成分可通过调控Toll样受体4(TLR4)/核因子κB(NF-κB)、丝裂原活化蛋白激酶(MAPK)、NOD样受体家族含pyrin结构域蛋白3(NLRP3)/caspase-1、磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)、核因子E2相关因子2(Nf2)/血红素加氧酶-1(HO-1)等信号通路,发挥抗炎、抗氧化应激、抑制细胞焦亡和自噬、抑制铁死亡的作用,减轻脓毒症肺损伤。本文就以上信号通路在脓毒症肺损伤中的作用机制以及中药有效成分调控信号通路治疗脓毒症肺损伤的研究进展进行综述,认为中医药治疗脓毒症肺损伤具有多成分、多靶点、整体调节的优势,治疗效果显著,研究前景广阔。未来可扩大中医药调控疾病靶点和机制研究范围,深入探讨其作用机制和治疗潜力,为急危重症的临床诊疗提供理论依据和经验参考。
Abstract:Sepsis is a systemic inflammatory response syndrome caused by infection,with resulting organ dysfunction being the key factor in mortality. The lung is one of the organs most frequently affected by sepsis. Recent studies have shown that active components of traditional Chinese medicine(TCM)can exert anti-inflammatory,anti-oxidative stress,anti-pyroptosis,and anti-ferroptosis effects by regulating signaling pathways such as Toll-like receptor 4(TLR4)/nuclear factor κB(NF-κB),mitogen-activated protein kinase(MAPK),NOD-like receptor family pyrin domain containing 3(NLRP3)/caspase-1,phosphatidylinositol 3-kinase/protein kinase B,and nuclear factor E2-related factor 2/heme oxygenase-1,thereby alleviating sepsis-induced lung injury. This article reviews the mechanisms of these signaling pathways in sepsis-induced lung injury and the research progress on TCM active components in regulating these pathways for the treatment of sepsis-induced lung injury. It is concluded that TCM has advantages of multi-components,multi-targets,and overall regulation,showing significant therapeutic effects and promising research prospects. In the future,the scope of research on TCM in regulating disease targets and mechanisms should be expanded to further explore its mechanisms and therapeutic potential,providing theoretical foundations and empirical references for the clinical diagnosis andtreatment of critical illnesses.
keywords: Traditional Chinese medicine Active components of traditional Chinese medicine Sepsis Lung injury Signaling pathways Multiple organ dysfunction syndrome
文章编号: 中图分类号:R563 R631 文献标志码:A
基金项目:国家自然科学基金项目(82460926,82460889);中央引导地方科技发展资金项目(2024SZY0962);中国民族医药学会科研项目(2023MY073-46);内蒙古自治区公立医院科研联合基金科技项目(2023GLLH0119);内蒙古自治区医师协会临床医学研究和临床新技术推广项 目(YSXH2024KYF022);内蒙古自治区中医医院科研计划项目(2024Z-A012)
附件
引用文本:
荣吉林太,苏和,张瑞芬,等.中药有效成分调控脓毒症肺损伤相关信号通路的研究进展[J].中国临床研究,2025,38(8):1145-1149.
荣吉林太,苏和,张瑞芬,等.中药有效成分调控脓毒症肺损伤相关信号通路的研究进展[J].中国临床研究,2025,38(8):1145-1149.
